Roche Hldgs (GENUS) Dividend yield

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
   CHF per share 
 Price  219.30
 Dividend  8.20
 Earnings  12.12
 Cash-flow  20.31
 Book value  30.89
 Equity  29.56

Roche Hldgs (GENUS) is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. Roche Hldgs (GENUS) is a company from Switzerland, and his stocks are publicly traded.

Roche Hldgs (GENUS) paid a total dividend of 5,683 million CHF last year, for a market value of 151,975 millions (Market Cap 152,040 millions). Dividend per share of Roche Hldgs (GENUS) is 8.20 CHF, and his stock market price 219.30 CHF.

According to the chart below, where dividend yield is displayed, Roche Hldgs (GENUS) has a dividend yield of 3.74%, which is higher than the amount offered by both the market average and companies from Switzerland. It is also bigger than average of Health Care industry. This high dividend yield might be a sign to worry about the future of the company so deeper analysis is needed.

In addition, you should compare Roche Hldgs (GENUS) dividend yield with other Pharmaceuticals and Biotechnology companies or firms from Switzerland.

Dividend yield of Roche Hldgs (GENUS)

Roche Hldgs (GENUS) Dividend Payout

About the ability of Roche Hldgs (GENUS) to maintain his current dividend of CHF 8.20 per share, an amount that accounts for 3.74%, we should study its payout ratio both on earnings and on cash-flows (see chart below). Roche Hldgs (GENUS) payout on ernings is currently 67.66%, which is higher than the market average, and companies of Health Care industry, which are 38.75% and 26.91% respectively. Both figures show that Roche Hldgs (GENUS) can have problems to keep with his present dividend yield.

The payout on earnings should be complemented with the payout on cash flow since it is this last amount the one which can be distributed to shareholders. Cash flow per share of Roche Hldgs (GENUS) is CHF 20.31 per share, which is higher than the dividend per share paid by the company of CHF 8.20, so the company generates enough cash to maintain his dividend in the future.

The following figure shows payout ratios over earnings and cashflow of Roche Hldgs (GENUS), compared againt world market average, Switzerland companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies. You might also need to check full financial report of Roche Hldgs (GENUS).

Roche Hldgs (GENUS) payout

Roche Hldgs (GENUS) Stock performance

Finally, last moth Roche Hldgs (GENUS) showed a return of -4.40% compared to a worldwide -3.60% average, and a -3.29% of Health Care firms. Over the last year, the company obtained a -10.40% versus a worldwide performance of a 13.88%. More detailed information can be seen in the following graph for Switzerland and Pharmaceuticals and Biotechnology firms.

Roche Hldgs (GENUS) stock and market return

Next companies

Rockcastle Global Real Estate Co. South Africa. Financials.

Rockwell Automation. USA. Industrials.

Rockwell Collins. USA. Industrials.

Rogers Comm. B. Canada. Telecommunications.

Rohm. Japan. Technology.

Rohto Pharmaceutical. Japan. Health Care.

Previous companies

Robert Half Intl. USA. Industrials.

RMB Holdings. South Africa. Financials.

Riocan REIT. Canada. Financials.

Rio Tinto Ltd.. Australia. Basic Materials.

Rio Tinto. UK. Basic Materials.

Rinnai Corp. Japan. Consumer Goods.



All rights reserved

 information advertisement legal

Dividends Ranking | Firm Report | Price to BookValue | Price to Cash-Flow | Price to Earnings | Return on Equity

Part of Enciclopedia Financiera Group

Disclaimer: Information on this site is only for informational purposes. Always consult a professional advisor before investing.